Key Points: Tenapanor is a first-in-class, minimally systemic sodium–hydrogen exchanger 3 inhibitor with a mechanism of action distinct from phosphate binders.Tenapanor alone or with phosphate binders led to 35%–49% of patient... ...

请注册登录后继续浏览